High Pretreatment DHEA Is Associated with Inferior Immunotherapy Response in Metastatic Non-Small Cell Lung Cancer.

MLA

Zhang, Yumeng, et al. “High Pretreatment DHEA Is Associated with Inferior Immunotherapy Response in Metastatic Non-Small Cell Lung Cancer.” Cancers, vol. 16, no. 6, Mar. 2024. EBSCOhost, https://doi.org/10.3390/cancers16061152.

APA

Zhang, Y., Darville, L., Hogue, S., Hallanger Johnson, J. E., Rose, T., Kim, Y., Bailey, A., Gray, J. E., & Robinson, L. A. (2024). High Pretreatment DHEA Is Associated with Inferior Immunotherapy Response in Metastatic Non-Small Cell Lung Cancer. Cancers, 16(6). https://doi.org/10.3390/cancers16061152

Chicago

Zhang, Yumeng, Lancia Darville, Stephanie Hogue, Julie E Hallanger Johnson, Trevor Rose, Youngchul Kim, Alexis Bailey, Jhanelle E Gray, and Lary A Robinson. 2024. “High Pretreatment DHEA Is Associated with Inferior Immunotherapy Response in Metastatic Non-Small Cell Lung Cancer.” Cancers 16 (6). doi:10.3390/cancers16061152.